What do Analysts Think About Catalyst Pharmaceuticals (CPRX)?

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best biotech stocks with high potential. HC Wainwright reiterated a Buy rating on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) on September 17 and set a $35 price target. Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now Similarly, in a report released on September 11, Jason Gerberry from Bank of America Securities also reiterated a Buy rating on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) and set a price targ ...